MONTEVIDEO, Uruguay, Oct. 24, 2017 /PRNewswire/ -- GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical companyin Latin America, today announced a realignment of its management structure to better suit the company´ strategy. To gain speed and focus on new launches in key geographies Mr. Mariano Garcia-Valino
"This will allow us to re-focus our priorities against our most important opportunities.", said Mr. Garcia-Valino in an internal communication. "As you know, we have recently announced a deal with EISAI, which gives us immediate access to 2 assets in Mexico and 4 in Brazil. At the same time, we have opportunity of launching Zevtera in Argentina in Q1 and Mexico has a good problem: it needs to accelerate to launch not one product, but three. Our focus on materializing our pipeline needs to be paramount."
Ms. Serna, a member of the original team that conceptualized the company together with Mr. Garcia-Valino at Advent International, has been instrumental in GBT's development in several fronts. Most recently, she was the company's Chief Strategy Officer. The company is in the final stages of recruiting to replace Julieta's old position. In the meantime, Nuno Toscano, from Advent's Portfolio Support Group, to temporarily fill the role.
About GBT-Grupo Biotoscana
GBT-Grupo Biotoscana (GBT) is a biopharmaceutical group that operates in the fast-growing Latin American region and focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation and orphan/rare diseases, among others. GBT is currently present throughout 10 Latin American countries where it operates under its companies Biotoscana, United Medical and LKM. GBT's strong portfolio combines world-class licenses and proprietary products. To find out more, please visit www.grupobiotoscana.com.
GBT - Grupo BiotoscanaMelissa AngeliniIR ManagerTel.: +55 11 5090 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/grupo-biotoscana-announces-corporate-restructure-300542010.html
SOURCE Grupo Biotoscana
Subscribe to our Free Newsletters!
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...
Palliative care is a specialized multifaceted care for patients with chronic or terminal illness to ...
Our kitchen and food has the best medicinal properties to fight stress. These are the top 10 foods ...View All